Anthem Biosciences Limited (NSE:ANTHEM)

Anthem Biosciences Revenue

In the fiscal year ending March 31, 2026, Anthem Biosciences had annual revenue of 21.24B INR with 14.80% growth. Anthem Biosciences had revenue of 6.11B in the quarter ending March 31, 2026, with 26.44% growth.

• Revenue: 21.24B
• Revenue Growth: +14.80%
• P/S Ratio: 19.98
• Revenue / Employee: 10.82M
• Employees: 1,963
• Market Cap: 424.35B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	21.24B	2.74B	14.80%
Mar 31, 2025	18.50B	4.30B	30.29%
Mar 31, 2024	14.20B	3.62B	34.24%
Mar 31, 2023	10.58B	-1.83B	-14.74%
Mar 31, 2022	12.41B	1.35B	12.24%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error